INVENTIVA S.A. ADR
INVENTIVA S.A. ADR
Depository Receipt · US46124U1079 · IVA · A2P796 (XNAS)
Overview
3,61 USD
5,72 % 0,19 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 19:12

Current Prices from INVENTIVA S.A. ADR

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
IVA
USD
06.06.2025 19:12
3,61 USD
3,41 USD
+5,72 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 6,34 % 2,41 % 15,92 % 36,04 % 1,84 % -73,14 %

Company Profile for INVENTIVA S.A. ADR Depository Receipt

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.

Company Data

Name INVENTIVA S.A. ADR
Company Inventiva S.A.
Symbol IVA
Website https://www.inventivapharma.com
Primary Exchange XNAS NASDAQ
WKN A2P796
ISIN US46124U1079
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Mr. Frederic Cren
Market Capitalization 322 Mio
Country France
Currency USD
Employees 0,1 T
Address 50 rue de Dijon, 21121 Daix
IPO Date 2020-07-10

Ticker Symbols

Name Symbol
Frankfurt 6IVA.F
NASDAQ IVA

More Shares

Investors who INVENTIVA S.A. ADR hold also have the following shares in their portfolio:
EX.IMP.BK.K. 23/27 MTN
EX.IMP.BK.K. 23/27 MTN Bond
NORATIS AG 21/27
NORATIS AG 21/27 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025